Repeatability of hypoxia dose painting by numbers based on EF5-PET in head and neck cancer

References

• Vanderstraeten B, Duthoy W, De Gersem W, et al. [18F]fluoro-deoxy-glucose positron emission tomography ([18F]FDG-PET) voxel intensity-based intensity-modulated radiation therapy (IMRT) for head and neck cancer. Radiother Oncol. 2006;79(3):249–258.
   PubMed Web of Science ®Google Scholar
• Gregoire V, Thorwarth D, Lee JA. Molecular imaging-guided radiotherapy for the treatment of head-and-neck squamous cell carcinoma: does it fulfill the promises? Semin Radiat Oncol. 2018;28(1):35–45.
   PubMed Web of Science ®Google Scholar
• Ling CC, Humm J, Larson S, et al. Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality. Int J Radiat Oncol. 2000;47(3):551–560.
   PubMed Web of Science ®Google Scholar
• Johansen S, Norman MH, Dale E, et al. Patterns of local-regional recurrence after conformal and intensity-modulated radiotherapy for head and neck cancer. Radiat Oncol. 2017;12:87.
   PubMed Web of Science ®Google Scholar
• Due AK, Vogelius IR, Aznar MC, et al. Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptake. Radiother Oncol. 2014;111(3):360–365.
   PubMed Web of Science ®Google Scholar
• Dirix P, Vandecaveye V, De Keyzer F, et al. Dose painting in radiotherapy for head and neck squamous cell carcinoma: value of repeated functional imaging with (18)F-FDG PET, (18)F-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI. J Nucl Med. 2009;50(7):1020–1027.
   PubMed Web of Science ®Google Scholar
• Houweling AC, Wolf AL, Vogel WV, et al. FDG-PET and diffusion-weighted MRI in head-and-neck cancer patients: implications for dose painting. Radiother Oncol. 2013;106(2):250–254.
   PubMed Web of Science ®Google Scholar
• Olteanu LAM, Duprez F, De Neve W, et al. Late mucosal ulcers in dose-escalated adaptive dose-painting treatments for head-and-neck cancer. Acta Oncol. 2018;57(2):262–268.
   PubMed Web of Science ®Google Scholar
• Madani I, Duprez F, Boterberg T, et al. Maximum tolerated dose in a phase I trial on adaptive dose painting by numbers for head and neck cancer. Radiother Oncol. 2011;101(3):351–355.
   PubMed Web of Science ®Google Scholar
• Rasmussen JH, Hakansson K, Vogelius IR, et al. Phase I trial of 18F-Fludeoxyglucose based radiation dose painting with concomitant cisplatin in head and neck cancer. Radiother Oncol. 2016;120(1):76–80.
   PubMed Web of Science ®Google Scholar
• Berwouts D, Madani I, Duprez F, et al. Long-term outcome of 18 F-fluorodeoxyglucose-positron emission tomography-guided dose painting for head and neck cancer: matched case-control study. Head Neck. 2017;39(11):2264–2275.
   PubMed Web of Science ®Google Scholar
• Lassen P, Primdahl H, Johansen J, et al. Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer. Radiother Oncol. 2014;113(3):310–316.
   PubMed Web of Science ®Google Scholar
• Moan JM, Amdal CD, Malinen E, et al. The prognostic role of 18F-fluorodeoxyglucose PET in head and neck cancer depends on HPV status. Radiother Oncol. 2019;140:54–61.
   PubMed Web of Science ®Google Scholar
• Horsman MR, Mortensen LS, Petersen JB, et al. Imaging hypoxia to improve radiotherapy outcome. Nat Rev Clin Oncol. 2012;9(12):674–687.
   PubMed Web of Science ®Google Scholar
• Fleming IN, Manavaki R, Blower PJ, et al. Imaging tumour hypoxia with positron emission tomography. Br J Cancer. 2015;112(2):238–250.
   PubMed Web of Science ®Google Scholar
• Komar G, Lehtio K, Seppanen M, et al. Prognostic value of tumour blood flow, [¹18F]EF5 and [¹18F]FDG PET/CT imaging in patients with head and neck cancer treated with radiochemotherapy. Eur J Nucl Med Mol Imaging. 2014;41(11):2042–2050.
   PubMed Web of Science ®Google Scholar
• Komar G, Seppanen M, Eskola O, et al. 18F-EF5: a new PET tracer for imaging hypoxia in head and neck cancer. J Nucl Med. 2008;49(12):1944–1951.
   PubMed Web of Science ®Google Scholar
• Silvoniemi A, Suilamo S, Laitinen T, et al. Repeatability of tumour hypoxia imaging using [18F]EF5 PET/CT in head and neck cancer. Eur J Nucl Med Mol Imaging. 2018;45(2):161–169.
   PubMed Web of Science ®Google Scholar
• Koch CJ, Evans SM. Optimizing hypoxia detection and treatment strategies. Semin Nucl Med. 2015;45(2):163–176.
   PubMed Web of Science ®Google Scholar
• Minn H, Gronroos TJ, Komar G, et al. Imaging of tumor hypoxia to predict treatment sensitivity. Curr Pharm Des. 2008;14(28):2932–2942.
   PubMed Web of Science ®Google Scholar
• Malinen E, Sovik A, Hristov D, et al. Adapting radiotherapy to hypoxic tumours. Phys Med Biol. 2006;51(19):4903–4921.
   PubMed Web of Science ®Google Scholar
• Grosu AL, Souvatzoglou M, Roper B, et al. Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer. Int J Radiat Oncol Biol Phys. 2007;69(2):541–551.
   PubMed Web of Science ®Google Scholar
• Thorwarth D, Eschmann SM, Paulsen F, et al. Hypoxia dose painting by numbers: a planning study. Int J Radiat Oncol Biol Phys. 2007;68(1):291–300.
   PubMed Web of Science ®Google Scholar
• Chang JH, Wada M, Anderson NJ, et al. Hypoxia-targeted radiotherapy dose painting for head and neck cancer using (18)F-FMISO PET: a biological modeling study. Acta Oncol. 2013;52(8):1723–1729.
   PubMed Web of Science ®Google Scholar
• Welz S, Monnich D, Pfannenberg C, et al. Prognostic value of dynamic hypoxia PET in head and neck cancer: Results from a planned interim analysis of a randomized phase II hypoxia-image guided dose escalation trial. Radiother Oncol. 2017;124(3):526–532.
   PubMed Web of Science ®Google Scholar
• Meijer G, Steenhuijsen J, Bal M, et al. Dose painting by contours versus dose painting by numbers for stage II/III lung cancer: practical implications of using a broad or sharp brush. Radiother Oncol. 2011;100(3):396–401.
   PubMed Web of Science ®Google Scholar
• van Schie MA, Steenbergen P, Dinh CV, et al. Repeatability of dose painting by numbers treatment planning in prostate cancer radiotherapy based on multiparametric magnetic resonance imaging. Phys Med Biol. 2017;62(14):5575–5588.
   PubMed Web of Science ®Google Scholar
• Knudtsen IS, van Elmpt W, Ollers M, et al. Impact of PET reconstruction algorithm and threshold on dose painting of non-small cell lung cancer. Radiother Oncol. 2014;113(2):210–214.
   PubMed Web of Science ®Google Scholar
• Arnesen MR, Knudtsen IS, Rekstad BL, et al. Dose painting by numbers in a standard treatment planning system using inverted dose prescription maps. Acta Oncol. 2015;54(9):1607–1613. Oct 21
   PubMed Web of Science ®Google Scholar
• Duprez F, De Neve W, De Gersem W, et al. Adaptive Dose Painting by Numbers for Head-and-Neck Cancer. Int J Radiat Oncol. 2011;80(4):1045–1055.
   PubMed Web of Science ®Google Scholar
• Okamoto S, Shiga T, Yasuda K, et al. High reproducibility of tumor hypoxia evaluated by 18F-fluoromisonidazole PET for head and neck cancer. J Nucl Med. 2013;54(2):201–207.
   PubMed Web of Science ®Google Scholar
• Nehmeh SA, Lee NY, Schroder H, et al. Reproducibility of intratumor distribution of (18)F-fluoromisonidazole in head and neck cancer. Int J Radiat Oncol Biol Phys. 2008;70(1):235–242.
   PubMed Web of Science ®Google Scholar
• Grkovski M, Schwartz J, Rimner A, et al. Reproducibility of (18)F-fluoromisonidazole intratumour distribution in non-small cell lung cancer. EJNMMI Res. 2016;6(1):79.
   PubMed Web of Science ®Google Scholar
• Rasmussen JH, Vogelius IR, Aznar MC, et al. Spatio-temporal stability of pre-treatment 18F-Fludeoxyglucose uptake in head and neck squamous cell carcinomas sufficient for dose painting. Acta Oncol. 2015;54(9):1416–1422.
   PubMed Web of Science ®Google Scholar
• Barker HE, Paget JT, Khan AA, et al. The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat Rev Cancer. 2015;15(7):409–425.
   PubMed Web of Science ®Google Scholar